Active Delivery of CRISPR System Using Targetable or Controllable Nanocarriers

Yan Lyu,Cheng Yang,Xiaomei Lyu,Kanyi Pu

DOI: https://doi.org/10.1002/smll.202005222

IF: 13.3

2021-03-24

Small

Abstract:<p>Among programmable nuclease‐based genome editing tools, the clustered regularly interspaced short palindromic repeats (CRISPR) system with accuracy and the convenient operation is most promising to be applied in gene therapy. The development of effective delivery carriers for the CRISPR system is the major premise to achieve practical applications. Although many nanocarrier‐mediated deliveries have been reported to be safer and cheaper over the physical and viral delivery, the accumulation at disease sites or controllability with the spatial or temporal resolution are still desired on nanocarriers to reduce side effects and off‐target from the CRISPR system. Therefore, the targetable and controllable nanocarriers to actively deliver the CRISPR system are summarized. The cell or even organ selective nanocarriers are introduced first, followed by the discussion of nanocarriers controlled by biochemical or physical signals. At last, the potential challenges faced by existing nanocarriers are discussed.</p>

materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology

What problem does this paper attempt to address?

The paper primarily explores how to achieve effective delivery of the CRISPR system using targeted and controllable nanocarriers. Specifically, the paper attempts to address the following key issues:

1. **Improving the delivery efficiency of the CRISPR system**: Traditional gene editing tools (such as zinc finger nucleases, TALENs, etc.) have issues with customization difficulty and complex recognition mechanisms. In contrast, the CRISPR system has more potential for gene therapy due to its ease of operation and clear recognition sites. However, efficient delivery of the CRISPR system remains a challenge.

2. **Reducing side effects and off-target effects**: Existing delivery methods (such as electroporation and viral delivery) are efficient in the laboratory but may cause damage to the cell membrane or trigger immune responses, even leading to tumor formation. Therefore, it is necessary to develop safer, cheaper, and more controllable non-viral nanocarriers to deliver the CRISPR system.

3. **Achieving precise control in time and space**: The ideal CRISPR nanocarrier should be able to efficiently load large molecules and remain stable in systemic circulation to prevent degradation of CRISPR components. More importantly, it should actively deliver the CRISPR system to the designated location and activate its editing activity within specific time and space ranges.

To achieve these goals, the paper discusses several strategies in detail, including targeted delivery of the CRISPR system through aptamer-target/ligand-receptor interactions, biomimetic techniques, and adjusting the surface charge of nanocarriers. Additionally, it introduces methods to control the release of the CRISPR system using in vivo biochemical signals (such as pH changes and reductive environments) and external physical signals (such as light and ultrasound).